Antibody arrays: Technical considerations and clinical applications in cancer

被引:95
作者
Sanchez-Carbayo, Marta [1 ]
机构
[1] Ctr Nacl Invest Oncol, Tumor Markers Grp, E-28029 Madrid, Spain
关键词
D O I
10.1373/clinchem.2005.059592
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Antibody arrays represent one of the high-throughput techniques that are able to detect multiple proteins simultaneously. One of the main advantages of this technology over other proteomic approaches is that the identities of the measured proteins are known or can be readily characterized, allowing a biological interpretation of the results. Features such as lower sample volume and antibody concentration requirements, higher format versatility, and reproducibility support the increasing use of antibody arrays in cancer research. Clinical applications include disease marker discovery for diagnosis, prognosis, and drug response, characterization of signaling and protein pathways, and modifications associated with disease development and progression. This report presents an overview of technical issues of the main antibody array formats and various applications in cancer research. Antibody arrays are high-throughput tools that improve the functional characterization of molecular bases for disease. Furthermore, identification and validation of protein expression patterns, characteristic of cancer progression, and tumor subtypes may intervene and improve tailored therapies in the clinical management of cancer patients. (c) 2006 American Association for Clinical Chemistry
引用
收藏
页码:1651 / 1659
页数:9
相关论文
共 55 条
[1]   The sentinel within: Exploiting the immune system for cancer biomarkers [J].
Anderson, KS ;
LaBaer, J .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) :1123-1133
[2]   Toward optimized antibody microarrays:: a comparison of current microarray support materials [J].
Angenendt, P ;
Glökler, J ;
Murphy, D ;
Lehrach, H ;
Cahill, DJ .
ANALYTICAL BIOCHEMISTRY, 2002, 309 (02) :253-260
[3]   Competitive assay formats for high-throughput affinity arrays [J].
Barry, R ;
Diggle, T ;
Terrett, J ;
Soloviev, M .
JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (03) :257-263
[4]   A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supports [J].
Berggren, K ;
Steinberg, TH ;
Lauber, WM ;
Carroll, JA ;
Lopez, MF ;
Chernokalskaya, E ;
Zieske, L ;
Diwu, ZJ ;
Haugland, RP ;
Patton, WF .
ANALYTICAL BIOCHEMISTRY, 1999, 276 (02) :129-143
[5]   Tissue profiling by mass spectrometry - A review of methodology and applications [J].
Caldwell, RL ;
Caprioli, RM .
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (04) :394-401
[6]   Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment -: A novel resource for biomarker and therapeutic target discovery [J].
Celis, JE ;
Gromov, P ;
Cabezón, T ;
Moreira, JMA ;
Ambartsumian, N ;
Sandelin, K ;
Rank, F ;
Gromova, I .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :327-344
[7]   Protein microarrays for multiplex analysis of signal transduction pathways [J].
Chan, SM ;
Ermann, J ;
Su, L ;
Fathman, CG ;
Utz, PJ .
NATURE MEDICINE, 2004, 10 (12) :1390-1396
[8]   Solid-phase and bead-based cytokine immunoassay: A comparison [J].
de Jager, W ;
Rijkers, GT .
METHODS, 2006, 38 (04) :294-303
[9]   Experimental design and analysis of antibody microarrays: Applying methods from cDNA arrays [J].
Eckel-Passow, JE ;
Hoering, A ;
Therneau, TM ;
Ghobrial, I .
CANCER RESEARCH, 2005, 65 (08) :2985-2989
[10]  
EK S, 2006, MOL CELL PROTEOMICS